Advanced Search
DSpace@MIT

Development of a collagen gel sandwich hepatocyte bioreactor for detecting hepatotoxicity of drugs and chemicals

Research and Teaching Output of the MIT Community

Show simple item record

dc.contributor.advisor Steven R. Tannenbaum. en_US
dc.contributor.author Farkas, Dóra, 1976- en_US
dc.contributor.other Massachusetts Institute of Technology. Biological Engineering Division. en_US
dc.date.accessioned 2005-06-02T19:44:17Z
dc.date.available 2005-06-02T19:44:17Z
dc.date.copyright 2004 en_US
dc.date.issued 2004 en_US
dc.identifier.uri http://hdl.handle.net/1721.1/18040
dc.description Thesis (Ph. D.)--Massachusetts Institute of Technology, Biological Engineering Division, 2004. en_US
dc.description Includes bibliographical references (leaves 124-140). en_US
dc.description.abstract Understanding the hepatotoxicity of drugs and chemicals is essential for progress in academic research, medical science and in the development of new pharmaceuticals. Studying hepatotoxicity in vitro is a challenging task because hepatocytes, the metabolically active cells of the liver, are very difficult to maintain in culture. After just 24 hours, the cells detach from the plate and die, and even if they survive they usually do not express the metabolic functions which they have in vivo. It has been observed by others that culturing hepatocytes between two layers of collagen type I maintains in vivo-like morphology and also many drug metabolizing enzymes for weeks. In spite of the research examining drug metabolism in collagen sandwiches, there are very few studies evaluating this system for investigating hepatotoxicity. We cultured primary rat hepatocytes in the collagen sandwich configuration and our goal was to optimize this system for long-term studies and to examine toxicity of a variety of hepatotoxins. By measuring secretions of urea and albumin, and P4501A activity, we determined the optimal cell density to be 50,000 cells/cm2. We also evaluated the need for epidermal growth factor (EGF) in our cultures, by comparing urea and albumin secretions in cultures grown with and without EGF. The cultures without EGF had significantly less secretion of both urea and albumin just two days after plating. Therefore, we decided to include EGF in the medium. The toxins we examined were aflatoxin B1, acetaminophen, carbon tetrachloride, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), methyl methane sulfonate (MMS), cadmium, vinyl acetate and dimethylformamide (DMF). The cells were sensitive to aflatoxin B1, MMS, MNNG and cadmium. However, they were en_US
dc.description.abstract (cont.) immune to acetaminophen, carbon tetrachloride, vinyl acetate and DMF. Our Western Blots showed that CYP1A, 2B and 3A were maintained in the culture for a week, but CYP2E1 was lost gradually over time. CYP2E1 is also the primary metabolic enzyme for acetaminophen, carbon tetrachloride and DMF. Thus, it is possible that the lack of toxicity is due to the loss of the enzyme responsible for the metabolism of these compounds. Immunity to vinyl acetate suggests that carboxylesterase is also lost in culture, since this enzyme is the one which converts vinyl acetate to acetaldehyde. The metabolism of acetaminophen was also examined with liquid chromatography and mass spectrometry. Liquid chromatography showed that acetaminophen is metabolized primarily to the sulfate and glucuronide metabolites. In order to investigate whether the glutathione adduct was formed, we synthesized the adduct and determined its retention time with liquid chromatography and its fragmentation pattern with mass spectrometry. We isolated the fraction with the same retention time from the medium of acetaminophen-treated cells, and showed that it contains a peak with the same mass to charge ratio and fragmentation pattern as the glutathione adduct. We also examined the conditioned medium from the hepatocytes to investigate the secreted protein profile, which could potentially be used to find toxicity biomarkers. We were able to remove most of the albumin from the medium using an immuno-affinity column containing anti-albumin antibodies bound to protein A-agarose beads ... en_US
dc.description.statementofresponsibility by Dóra Farkas. en_US
dc.format.extent 151, [23] leaves en_US
dc.format.extent 9928338 bytes
dc.format.extent 9950153 bytes
dc.format.mimetype application/pdf
dc.format.mimetype application/pdf
dc.language.iso eng en_US
dc.publisher Massachusetts Institute of Technology en_US
dc.rights M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. en_US
dc.rights.uri http://dspace.mit.edu/handle/1721.1/7582
dc.subject Biological Engineering Division. en_US
dc.title Development of a collagen gel sandwich hepatocyte bioreactor for detecting hepatotoxicity of drugs and chemicals en_US
dc.type Thesis en_US
dc.description.degree Ph.D. en_US
dc.contributor.department Massachusetts Institute of Technology. Biological Engineering Division. en_US
dc.identifier.oclc 57350915 en_US


Files in this item

Name Size Format Description
57350915.pdf 9.468Mb PDF Preview, non-printable (open to all)
57350915-MIT.pdf 9.489Mb PDF Full printable version (MIT only)

This item appears in the following Collection(s)

Show simple item record

MIT-Mirage